DDX46 (Prp5-like DEAD-box protein): A Potential Drug Target and Biomarker

Target Name: DDX46

NCBI ID: G9879

DDX46

DDX46 (Prp5-like DEAD-box protein): A Potential Drug Target and Biomarker

Introduction

Prp5, also known as DDX46, is a protein that plays a crucial role in the regulation of cell death and survival. It is a member of the DEAD (DNA-binding protein) family, which includes several proteins involved in DNA damage repair and cell death regulation. Prp5 is unique among its family members due to its ability to interact with DNA and induce cell death in response to DNA damage.

The identification and characterization of Prp5 have led to the development of a new drug target and potential biomarker for various diseases, including cancer. This article will discuss the properties of Prp5, its functions in cell death regulation, and its potential as a drug target and biomarker.

Properties of Prp5

Prp5 is a 23.5 kDa protein that contains 106 amino acid residues. It has a characteristic Rossmann-fold (5) and a calculated molecular mass of 21.1 kDa. Prp5 is predominantly localized to the cytoplasm and is also found in the nucleus.

Function of Prp5

Prp5 is involved in the regulation of cell death and survival, specifically in the context of DNA damage repair. It has been shown to play a critical role in the DNA double-strand break repair pathway, where it can interact with the double -strand break site and induce cell death when DNA damage occurs.

In addition to its role in DNA double-strand break repair, Prp5 is also involved in the regulation of cell survival and apoptosis. It has been shown to promote cell survival by inhibiting cell death signals, such as the production of reactive oxygen species (ROS). Prp5 has also been shown to play a role in cell cycle regulation, where it can alter the level of cell cycle progression.

Potential as a Drug Target

The potential of Prp5 as a drug target is based on its involvement in cell death regulation and its ability to interact with DNA. Several studies have shown that Prp5 can be a drug target for various diseases, including cancer.

For cancer, Prp5 has been shown to promote the growth and survival of cancer cells. Its role in this process is thought to be due to its ability to inhibit cell death signals, such as the production of ROS. Additionally , Prp5 has been shown to promote the formation of cancer stem cells (17), which can contribute to the development and progression of cancer.

As a potential drug target, Prp5 has been the focus of several research studies aimed at inhibiting its activity (18, 19). One approach is to target Prp5 directly with small molecules, such as inhibitors of its enzymes or modulators of its activity (20 ). Another approach is to target Prp5 through its downstream signaling pathways, such as the DNA double-strand break repair pathway.

Potential as a Biomarker

Prp5 has also been identified as a potential biomarker for various diseases, including cancer. Its involvement in cell death regulation and its ability to interact with DNA make it an attractive candidate for use as a biomarker for cancer and other diseases.

There are several methods that can be used to measure the levels of Prp5 in biological tissues or cells, including Western blotting, immunofluorescence, and mass spectrometry. These methods can be used to determine the levels of Prp5 in different biological samples, such as tissue samples, cells, or urine samples.

Conclusion

Prp5 is a protein that plays a crucial role in the regulation of cell death and survival. Its unique ability to interact with DNA and induce cell death in response to DNA damage has led to its identification as a potential drug target for various diseases, including cancer. The potential of Prp5 as a biomarker for cancer and other diseases is also an exciting area of 閳ュ??濯焑search. Further studies are needed to fully understand the properties and functions of Prp5, as well as its potential as a drug target and biomarker.

Protein Name: DEAD-box Helicase 46

Functions: Plays an essential role in splicing, either prior to, or during splicing A complex formation

The "DDX46 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DDX46 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets